Education
About Us
Working with TipRanks
Follow Us
Exact Sciences Corp. (EXAS)
NASDAQ:EXAS
Total Valuation
Exact Sciences has a market cap or net worth of $9.72B. The enterprise value is $12.15B.
Market Cap$9.72B
Enterprise Value$12.15B
Share Statistics
Exact Sciences has 188,637,680 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding188,637,680
Owned by Insiders1.07%
Owned by Institutions1.05%
Financial Efficiency
Exact Sciences’s return on equity (ROE) is -0.43 and return on invested capital (ROIC) is -19.12%.
Return on Equity (ROE)-0.43
Return on Assets (ROA)-0.17
Return on Invested Capital (ROIC)-19.12%
Return on Capital Employed (ROCE)-0.20
Revenue Per Employee399.84K
Profits Per Employee-149.11K
Employee Count6,900
Asset Turnover0.47
Inventory Turnover5.17
Valuation Ratios
The current PE Ratio of Exact Sciences is -10.06. Exact Sciences’s PEG ratio is -0.03.
PE Ratio-10.06
PS Ratio0.00
PB Ratio4.31
Price to Fair Value4.31
Price to FCF138.84
Price to Operating Cash Flow49.16
PEG Ratio-0.03
Income Statement
In the last 12 months, Exact Sciences had revenue of 2.76B and earned -1.03B in profits. Earnings per share was -5.59.
Revenue2.76B
Gross Profit1.92B
Operating Income-1.05B
Pretax Income-1.04B
Net Income-1.03B
EBITDA-788.73M
Earnings Per Share (EPS)-5.59
Cash Flow
In the last 12 months, operating cash flow was 323.66M and capital expenditures -129.51M, giving a free cash flow of 194.14M billion.
Operating Cash Flow323.66M
Free Cash Flow194.14M
Free Cash Flow per Share1.03
Dividends & Yields
Exact Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.78
52-Week Price Change-18.63%
50-Day Moving Average45.48
200-Day Moving Average55.79
Relative Strength Index (RSI)68.44
Average Volume (3m)2.72M
Important Dates
Exact Sciences upcoming earnings date is Feb 24, 2026, TBA Not Confirmed.
Last Earnings DateOct 29, 2025
Next Earnings DateFeb 24, 2026
Ex-Dividend Date―
Financial Position
Exact Sciences as a current ratio of 2.15, with Debt / Equity ratio of 105.19%
Current Ratio2.15
Quick Ratio1.92
Debt to Market Cap0.25
Net Debt to EBITDA-2.73
Interest Coverage Ratio-32.80
Taxes
In the past 12 months, Exact Sciences has paid -7.30M in taxes.
Income Tax-7.30M
Effective Tax Rate<0.01
Enterprise Valuation
Exact Sciences EV to EBITDA ratio is -15.85, with an EV/FCF ratio of 167.73.
EV to Sales4.53
EV to EBITDA-15.85
EV to Free Cash Flow167.73
EV to Operating Cash Flow59.39
Balance Sheet
Exact Sciences has $786.17M in cash and marketable securities with ― in debt, giving a net cash position of $1.74B billion.
Cash & Marketable Securities$786.17M
Total Debt―
Net Cash$1.74B
Net Cash Per Share$9.20
Tangible Book Value Per Share-$5.29
Margins
Gross margin is 68.19%, with operating margin of -38.01%, and net profit margin of -37.29%.
Gross Margin68.19%
Operating Margin-38.01%
Pretax Margin-37.56%
Net Profit Margin-37.29%
EBITDA Margin-28.59%
EBIT Margin-36.40%
Analyst Forecast
The average price target for Exact Sciences is $69.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$69.67
Price Target Upside35.15% Upside
Analyst ConsensusStrong Buy
Analyst Count20
Revenue Growth Forecast11.57%
EPS Growth Forecast-315.25%